Results of Studies Comparing 111In-DTPA-Octreotide Scintigraphy with MIBG Scintigraphy for Neuroblastoma*
| Authors (reference) | Radionuclides | Patients | Sensitivity | ||
|---|---|---|---|---|---|
| MIBG | 111In-DTPA-octreotide | ||||
| Limouris et al. (53) | 123I-MIBG and 111In-DTPA | 7 | 83% | 55% | |
| Shalaby Rana et al. (54) | 131I-MIBG and 111In-DTPA | 7 | 86% | 57% | |
| Kropp et al. (55) | 123I-MIBG and 111In-DTPA | 22 | 85% | 70% | |
| Schilling et al. (56) | 123I-MIBG and 111In-DTPA | 88 | 94% | 64% | |
↵* No 111In-DTPA-octreotide SPECT imaging was performed in these studies.